Residual cancer burden (RCB) in breast cancer patients treated with taxane- and anthracycline-based neoadjuvant chemotherapy: The effect of race.

Cancer Patients ◽

Breast Cancer Patients ◽

Residual Cancer ◽

Cancer Burden ◽

Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients

Breast Cancer Research and Treatment ◽

10.1007/s10549-017-4150-7 ◽

2017 ◽

Vol 162 (3) ◽

pp. 533-540 ◽

Cited By ~ 5

Author(s):

Emerson A. Lim ◽

Jacqueline E. Gunther ◽

Hyun K. Kim ◽

Molly Flexman ◽

Hanina Hibshoosh ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Optical Tomography ◽

Diffuse Optical Tomography ◽

Breast Cancer Patients ◽

Residual Cancer ◽

Cancer Burden ◽

Abstract GS6-04: The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2- breast cancer patients from ABCSG 34

10.1158/1538-7445.sabcs17-gs6-04 ◽

2018 ◽

Cited By ~ 1

Author(s):

PC Dubsky ◽

C Fesl ◽

CF Singer ◽

G Pfeiler ◽

R Kronenwett ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Residual Cancer ◽

Cancer Burden ◽

Residual Cancer Burden ◽

Her2 Breast Cancer

MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Academic Radiology ◽

10.1016/j.acra.2020.10.020 ◽

2020 ◽

Author(s):

Sadia Choudhery ◽

Daniel Gomez-Cardona ◽

Christopher P Favazza ◽

Tanya L Hoskin ◽

Tufia C Haddad ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Pathological Complete Response ◽

Molecular Subtype ◽

Complete Response ◽

Breast Cancer Patients ◽

Residual Cancer ◽

Cancer Burden ◽

Predictive value of 18F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) ◽

10.1016/j.remnie.2021.05.007 ◽

2021 ◽

Author(s):

Tuğba Başoğlu ◽

Salih Özgüven ◽

Hülya Şahin Özkan ◽

Merve Çınar ◽

Osman Köstek ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Predictive Value ◽

Breast Cancer Patients ◽

Residual Cancer ◽

Residual Cancer Burden ◽

Pet Ct ◽

18F Fdg ◽

Fdg Pet Ct

Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy

Annals of Surgical Oncology ◽

10.1245/s10434-019-07741-w ◽

2019 ◽

Vol 26 (13) ◽

pp. 4274-4283 ◽

Cited By ~ 2

Author(s):

Hannah Deborah Müller ◽

Florian Posch ◽

Christoph Suppan ◽

Ute Bargfrieder ◽

Melanie Gumpoldsberger ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factor ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Residual Cancer ◽

Cancer Burden ◽

P3-14-05: Evaluation of Residual Cancer Burden Index (RCBI) as a Predictor of Disease Free Survival in a Non-Selected Cohort of Breast Cancer Patients Treated in the Neoadjuvant Setting.

10.1158/0008-5472.sabcs11-p3-14-05 ◽

2011 ◽

Author(s):

J-A Perez-Fidalgo ◽

M Martinez ◽

J Ferrer ◽

V Pons ◽

O Burgues ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Disease Free Survival ◽

Breast Cancer Patients ◽

Residual Cancer ◽

Free Survival ◽

Cancer Burden ◽

Residual Cancer Burden ◽

Disease Free

Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Breast Cancer Research and Treatment ◽

10.1007/s10549-017-4303-8 ◽

2017 ◽

Vol 165 (1) ◽

pp. 181-191 ◽

Cited By ~ 21

Author(s):

Jeffrey I. Campbell ◽

Christina Yau ◽

Polina Krass ◽

Dan Moore ◽

Lisa A. Carey ◽

...

Keyword(s):

Breast Cancer ◽

Pathologic Complete Response ◽

Complete Response ◽

Cancer Staging ◽

Residual Cancer ◽

Cancer Burden ◽

Residual Cancer Burden ◽

American Joint Committee

Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy

PLoS ONE ◽

10.1371/journal.pone.0234191 ◽

2020 ◽

Vol 15 (6) ◽

pp. e0234191 ◽

Cited By ~ 3

Author(s):

Anne-Sophie Hamy ◽

Lauren Darrigues ◽

Enora Laas ◽

Diane De Croze ◽

Lucian Topciu ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Value ◽

Breast Cancer Subtype ◽

Residual Cancer ◽

Cancer Burden ◽

Residual Cancer Burden ◽

Cancer Subtype

Histological Evaluation of Therapeutic Effect and RCB (Residual Cancer Burden) Index in Primary Breast Cancer Operated after Neoadjuvant Chemotherapy: Retrospective Study of the Clinicopathological Findings and Prognosis

The Showa University Journal of Medical Sciences ◽

10.15369/sujms.29.181 ◽

2017 ◽

Vol 29 (2) ◽

pp. 181-192

Author(s):

Seiya HAJIKANO ◽

Yuko HIROTA ◽

Nobukazu SHIMA ◽

Reika SUZUKI ◽

Terumasa SAWADA ◽

...

Keyword(s):

Breast Cancer ◽

Retrospective Study ◽

Therapeutic Effect ◽

Primary Breast Cancer ◽

Histological Evaluation ◽

Residual Cancer ◽

Cancer Burden ◽

Residual Cancer Burden ◽

Clinicopathological Findings

Abstract P2-16-09: Residual cancer burden in patients with early stage triple negative breast cancer who progress on anthracycline-based neoadjuvant chemotherapy in an ongoing clinical trial (ARTEMIS)

10.1158/1538-7445.sabcs19-p2-16-09 ◽

2020 ◽

Cited By ~ 1

Author(s):

Haven Garber ◽

Gaiane Rauch ◽

Beatriz Adrada ◽

Rosalind Candelaria ◽

Elizabeth Mittendorf ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Early Stage ◽

Ongoing Clinical Trial ◽

Residual Cancer ◽

Cancer Burden ◽